BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28388540)

  • 1. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
    Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
    Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
    Chen J; Miller EM; Gallo KA
    Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.
    Duan R; Ginsburg E; Vonderhaar BK
    Mol Cell Endocrinol; 2008 Jan; 281(1-2):9-18. PubMed ID: 18022314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen.
    Hao H; d'Alincourt-Salazar M; Kelley KM; Shatnawi A; Mukherjee S; Shah YM; Ratnam M
    Oncogene; 2007 Dec; 26(57):7872-84. PubMed ID: 17599049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.
    Rangasamy V; Mishra R; Mehrotra S; Sondarva G; Ray RS; Rao A; Chatterjee M; Rana B; Rana A
    Cancer Res; 2010 Feb; 70(4):1731-40. PubMed ID: 20145118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
    Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
    Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
    Martini PG; Katzenellenbogen BS
    Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
    Das S; Sondarva G; Viswakarma N; Nair RS; Osipo C; Tzivion G; Rana B; Rana A
    J Biol Chem; 2015 Aug; 290(35):21705-12. PubMed ID: 26152725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
    Hockings JK; Degner SC; Morgan SS; Kemp MQ; Romagnolo DF
    Breast Cancer Res; 2008; 10(2):R29. PubMed ID: 18377656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells.
    Marchiori AC; Casolari DA; Nagai MA
    Braz J Med Biol Res; 2008 Jul; 41(7):579-82. PubMed ID: 18641796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.